![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1345925 | 6480464 | [potassium chromateVI co-treated with epigallocatechin gallate] results in increased expression of RPL18A mRNA | CTD | PMID:22079256 | 1,2-dichloroethane | increases expression | EXP | | 6480464 | ethylene dichloride results in increased expression of RPL18A mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPL18A mRNA | CTD | PMID:22206623 | 1-naphthyl isothiocyanate | increases expression | ISO | RGD:1302976 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of RPL18A mRNA | CTD | PMID:20551477 | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of RPL18A mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RPL18A mRNA | CTD | PMID:17942748 | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | RGD:1302976 | 6480464 | 2 more ... | CTD | PMID:21394737 | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | EXP | | 6480464 | 2 more ... | CTD | PMID:30294300 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RPL18A mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RPL18A mRNA | CTD | PMID:18796159, PMID:31511937 | 3H-1,2-dithiole-3-thione | increases expression | ISO | RGD:1302976 | 6480464 | 1, 2-dithiol-3-thione results in increased expression of RPL18A mRNA | CTD | PMID:19162173 | ammonium chloride | affects expression | ISO | RGD:1302976 | 6480464 | Ammonium Chloride affects the expression of RPL18A mRNA | CTD | PMID:16483693 | arsenous acid | decreases expression | ISO | RGD:1345925 | 6480464 | Arsenic Trioxide results in decreased expression of RPL18A mRNA | CTD | PMID:15725085 | bexarotene | increases expression | ISO | RGD:1302976 | 6480464 | bexarotene results in increased expression of RPL18A mRNA | CTD | PMID:16648578 | bisphenol A | increases expression | ISO | RGD:1302976 | 6480464 | bisphenol A results in increased expression of RPL18A mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | RGD:1345925 | 6480464 | bisphenol A results in decreased expression of RPL18A mRNA | CTD | PMID:29275510 | Brodifacoum | decreases expression | ISO | RGD:1302976 | 6480464 | bromfenacoum results in decreased expression of RPL18A protein | CTD | PMID:28903499 | cadmium atom | increases expression | ISO | RGD:1345925 | 6480464 | Cadmium results in increased expression of RPL18A mRNA | CTD | PMID:24376830 | cadmium dichloride | decreases methylation | ISO | RGD:1302976 | 6480464 | Cadmium Chloride results in decreased methylation of RPL18A promoter | CTD | PMID:22457795 | chloropicrin | increases expression | ISO | RGD:1345925 | 6480464 | chloropicrin results in increased expression of RPL18A mRNA | CTD | PMID:26352163 | cylindrospermopsin | increases expression | EXP | | 6480464 | cylindrospermopsin results in increased expression of RPL18A mRNA | CTD | PMID:20936652 | diarsenic trioxide | decreases expression | ISO | RGD:1345925 | 6480464 | Arsenic Trioxide results in decreased expression of RPL18A mRNA | CTD | PMID:15725085 | disodium selenite | increases expression | ISO | RGD:1345925 | 6480464 | Sodium Selenite results in increased expression of RPL18A mRNA | CTD | PMID:18175754 | doxorubicin | affects expression | ISO | RGD:1345925 | 6480464 | Doxorubicin affects the expression of RPL18A protein | CTD | PMID:29385562 | endosulfan | increases expression | ISO | RGD:1302976 | 6480464 | Endosulfan results in increased expression of RPL18A mRNA | CTD | PMID:29391264 | enzyme inhibitor | multiple interactions | ISO | RGD:1345925 | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RPL18A protein | CTD | PMID:23301498 | flutamide | increases expression | ISO | RGD:1302976 | 6480464 | Flutamide results in increased expression of RPL18A mRNA | CTD | PMID:24136188 | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of RPL18A mRNA | CTD | PMID:25629700 | folic acid | multiple interactions | EXP | | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPL18A mRNA | CTD | PMID:22206623 | glafenine | increases expression | ISO | RGD:1302976 | 6480464 | Glafenine results in increased expression of RPL18A mRNA | CTD | PMID:24136188 | hydralazine | multiple interactions | ISO | RGD:1345925 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL18A mRNA | CTD | PMID:17183730 | Monobutylphthalate | decreases expression | EXP | | 6480464 | monobutyl phthalate results in decreased expression of RPL18A protein | CTD | PMID:20553848 | nefazodone | increases expression | ISO | RGD:1302976 | 6480464 | nefazodone results in increased expression of RPL18A mRNA | CTD | PMID:24136188 | nimesulide | increases expression | ISO | RGD:1302976 | 6480464 | nimesulide results in increased expression of RPL18A mRNA | CTD | PMID:24136188 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of RPL18A mRNA | CTD | PMID:17562736 | perfluorooctanoic acid | increases expression | ISO | RGD:1302976 | 6480464 | perfluorooctanoic acid results in increased expression of RPL18A mRNA | CTD | PMID:19162173 | potassium chromate | multiple interactions | ISO | RGD:1345925 | 6480464 | [potassium chromateVI co-treated with epigallocatechin gallate] results in increased expression of RPL18A mRNA | CTD | PMID:22079256 | potassium chromate | increases expression | ISO | RGD:1345925 | 6480464 | potassium chromateVI results in increased expression of RPL18A mRNA | CTD | PMID:22079256 | rotenone | increases expression | ISO | RGD:1302976 | 6480464 | Rotenone results in increased expression of RPL18A mRNA | CTD | PMID:28374803 | sodium dichromate | increases expression | ISO | RGD:1302976 | 6480464 | sodium bichromate results in increased expression of RPL18A mRNA | CTD | PMID:22561333 | sodium fluoride | decreases expression | EXP | | 6480464 | Sodium Fluoride results in decreased expression of RPL18A protein | CTD | PMID:28918527 | stigmasterol | decreases expression | EXP | | 6480464 | Stigmasterol results in decreased expression of RPL18A mRNA | CTD | PMID:30245210 | streptozocin | increases expression | ISO | RGD:1302976 | 6480464 | Streptozocin results in increased expression of RPL18A mRNA | CTD | PMID:16684804 | streptozocin | multiple interactions | ISO | RGD:1302976 | 6480464 | vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of RPL18A mRNA] | CTD | PMID:16684804 | tolcapone | affects binding | ISO | RGD:1302976 | 6480464 | tolcapone binds to RPL18A protein | CTD | PMID:19783845 | valproic acid | multiple interactions | ISO | RGD:1345925 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of RPL18A mRNA | CTD | PMID:17183730 | valproic acid | increases methylation | ISO | RGD:1345925 | 6480464 | Valproic Acid results in increased methylation of RPL18A gene | CTD | PMID:29154799 | vanadyl sulfate | multiple interactions | ISO | RGD:1302976 | 6480464 | vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of RPL18A mRNA] | CTD | PMID:16684804 | |